For example, in breast cancer, KCNMA1, KCNJ3, KCNN4, and KCNK9 are associated with estrogen receptor expression and lymph node and brain metastases; KCNMA1 is also overexpressed in hormone-sensitive prostate cancer cells. This evidence concerns the gene KCNMA1 and prostate cancer.